Business
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantagesWhite Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of Australian Patent No. 2022229818, granted by the Australian Patent Office on October 16, 2025.The.
About this update from Envoy Medical, Inc.
[{"type":"text","content":"Patent strengthens Company's global intellectual property portfolio and reinforces the Company's commitment to establishing and protecting competitive advantages","length":169,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of Australian Patent No. 2022229818, granted by the Australian Patent Office on October 16, 2025.","length":355,"tagName":"p"},{"type":"text","content":"The newly issued patent strengthens the Company's global IP portfolio in an important international market that is also the home country of its largest competitor. The Company remains focused on establishing differentiation within the marketplace and protecting competitive advantages. The Company understands the staggering cost – both in raw capital investment, time, and opportunity cost – it would take a competitor to recreate Envoy Medical's fully implanted cochlear implant, and it will continue to make important investments to further strengthen its technology and product pipeline.","length":609,"tagName":"p"},{"type":"text","content":""It has taken Envoy Medical roughly $300 million dollars and a few decades to get to where it is today," said Brent Lucas, Chief Executive Officer of Envoy Medical. "We have pioneered two fully implanted hearing technologies. We are the only company to have gotten a fully implanted active hearing device through the FDA approval process to date. We received Breakthrough Device Designation from the FDA for our fully implanted investigational cochlear implant. We believe we are going to be a leader as the industry moves to fully implanted hearing implants, and we will continue to carefully protect ourselves and make it difficult on others to recreate what we have in our product portfolio."","length":715,"tagName":"p"},{"type":"text","content":"The patent, titled "Cochlear Implant System with Improved Input Signal-To-Noise Ratio," covers innovations involving an input source with a sensor and a powered signal modifier that includes an amplifier. In this design, the sensor receiv...